haemophilia therapy for the real world -...

1

EU/COAG/17/-0006e November 2017 11:30 The reality of advancing haemophilia care: Santiago Bonanad Boix (Valencia, Spain) Welcome and introduction 11:45 Extending our clinical experience of the treatment Andres Brainsky (King of Prussia, PA, USA) of haemophilia 11:55 Laboratory monitoring to support individualisation Kenneth Friedman (Milwaukee, WI, USA) of haemophilia management 12:10 Optimising the use of rVIII-SingleChain in Christoph Bidlingmaier (Munich, Germany) haemophilia A: Practical experience from Munich 12:30 rIX-FP in the real world of haemophilia B Elena Santagostino (Milan, Italy) management: Practical experience from Milan 12:50 Q & A and closing remarks Santiago Bonanad Boix and faculty panel 13:00 Close of symposium Programme Chair: Santiago Bonanad Boix Haemophilia Therapy for the Real World Wednesday 7 th February 2018 at 11:30–13:00 Auditorio A (Plenary Room), Palacio Municipal, Madrid, Spain

Upload: phungque

Post on 27-Mar-2018

216 views

Category:

Documents

3 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: Haemophilia Therapy for the Real World - …eahadcongress.com/wp-content/uploads/2018/01/CSL-Behring-Satellite... · Haemophilia Therapy for the Real World Wednesday 7th February

EU/COAG/17/-0006e November 2017

11:30 The reality of advancing haemophilia care: Santiago Bonanad Boix (Valencia, Spain) Welcome and introduction

11:45 Extending our clinical experience of the treatment Andres Brainsky (King of Prussia, PA, USA) of haemophilia

11:55 Laboratory monitoring to support individualisation Kenneth Friedman (Milwaukee, WI, USA) of haemophilia management

12:10 Optimising the use of rVIII-SingleChain in Christoph Bidlingmaier (Munich, Germany) haemophilia A: Practical experience from Munich

12:30 rIX-FP in the real world of haemophilia B Elena Santagostino (Milan, Italy) management: Practical experience from Milan

12:50 Q & A and closing remarks Santiago Bonanad Boix and faculty panel

13:00 Close of symposium

Programme Chair: Santiago Bonanad Boix

Haemophilia Therapy for the Real WorldWednesday 7th February 2018 at 11:30–13:00Auditorio A (Plenary Room), Palacio Municipal, Madrid, Spain

haemophilia · PDF file Magazine the Irish Haemophilia Society Magazine of the Irish Haemophilia Society 3 Hi everyone, Welcome to the Winter issue

Molecular diagnosis of haemophilia and other bleeding ... · Bleeding Disorder Gene/ Chromosome Reference Haemophilia A F8 / Ch.X Jayandharan et al, Haemophilia, 2004 Jayandharan

Haemophilia Scotland Newsletter

Behring y Boschetti

Dimension-dade Behring Emergency1

Essay Haemophilia

Understanding haemophilia

PROTOCOL HAEMOPHILIA MEDICATION THERAPY ADHERENCE CLINIC ... · PDF filecare issues, especially in ... Haemophilia Medication Therapy Adherence Clinic (HMTAC) ... HAEMOPHILIA MEDICATION

Haemophilia News Vol. 14 - Haemophilia Society of Singapore

protocol haemophilia medication therapy adherence clinic

REVIEW (corrected version) Haemophilia A and haemophilia B: … · VIII gene in haemophilia A and the coagulation factor IX gene in haemophilia B. Although muta-tional heterogeneity

The Nurse and Comprehensive Haemophilia Care · The Nurse and Comprehensive Haemophilia Care Janine Furmedge The Royal Childrens Hospital ... • Haemophilia ID cards for patients

Gene therapy for haemophilia · 2019-10-23 · gene therapy target the gene with the mutation, but each type of therapy works differently. There are currently gene therapy clinical

Bleeding Child & Haemophilia

Haemophilia July 2010

WELCOME [] · Jaime Chase Australian Haemophilia Nurses’ Group Stephen Matthews Australian Haemophilia Nurses’ Group Alison Morris Australian and NZ Physiotherapy Haemophilia

Future prospects for haemophilia therapy · Assay problems with EHL products: Kitchen S et al. Haemophilia 22 (Suppl. 5): 72-77 (2016) •For some extended half-life FVIII and FIX

Gene therapy and haemophilia

Haemophilia booklet (2013) - Haemophilia Foundation · PDF fileWHAT IS HAEMOPHILIA? Haemophilia is an inherited bleeding disorder where blood doesn’t clot properly. It is caused

Haemophilia: The Role of Nurses - storage.googleapis.com · Haemophilia and Allied Disorders (EAHAD) Nurses’ Committee developed a curriculum to standardise and benchmark haemophilia

Emil von Behring für die Universitätsstadt BEHRING-ROUTE ... · Die Behring-Route Die Bedeutung des ersten Medizin-Nobel-preisträgersundMarburgerFirmengründers Emil von Behring

Haemophilia & orthopaedics

NOVO NORDISK HAEMOPHILIA · PDF fileNOVO NORDISK HAEMOPHILIA FOUNDATION Dear Reader, Novo Nordisk Haemophilia Foundation (NNHF) has pleasure in presenting its

Novel treatments in haemophilia and other bleeding ... · Gene therapy Clinical trial to start for gene therapy in people with haemophilia A and inhibitors Spark has received FDA

Haemophilia a Done)

Treatment Guidelines for Haemophilia · PDF fileTreatment Guidelines for Haemophilia Haemophilia is an inherited, x-linked, lifelong bleeding disorder which affects males almost exclusively

Haemophilia - HSEpediaAcquired haemophilia usually develops when people are older and can affect both men and women. How common is haemophilia? Haemophilia is rare. In Australia there

CSL Behring RecombinantFacilityRCFLengnau CSL Behring · CSL Behring–RecombinantFacilityRCFLengnau Teamleader Nebenanlagen (Plant Utilities) Aufbau und Letiung des Betreibs - und

Haemophilia Therapy for the Real World - EAHADeahadcongress.com/wp-content/uploads/2018/01/CSL-Behring-Satellite... · EU/COAG/17/-0006e November 2017 11:30 The reality of advancing

HAEMOPHILIA & SPORT - pfizerpro.co.uk · haemophilia & sport 3 introduction 4 what haemophilia is 6 what to look out for if you have haemophilia 8 haemophilia & sport 10 what physical

Treatment Guidelines for Haemophilia in South Africa National... · Treatment Guidelines for Haemophilia Treatment Guidelines for Haemophilia in South Africa These guidelines have

Haemophilia: Royal disease

CDISC Implementation on Haemophilia Trial Data - PhUSE Denmark SDE Presentations/CDISC... · Agenda About Haemophilia Introduction to Haemophilia trial data Our approach to implementing